Shaji Sebastian
National Health Service
Internal medicineSurgeryRetrospective cohort studyAdverse effectCohort studyInfliximabInflammatory Bowel DiseasesInflammatory bowel diseaseDiscontinuationUlcerative colitisGastrointestinal agentINCEPTION COHORTEuropean populationIn patientCost savingsPharmacotherapyMedicineCohort
1Publications
1H-index
29Citations
Publications 2
Newest
#1Johan BurischH-Index: 38
#2Hillel VardiH-Index: 21
view all 33 authors...
#1Gionata FiorinoH-Index: 51
Last. Silvio Danese (Humanitas University)H-Index: 100
view all 24 authors...
Background & Aims Infliximab is a safe and effective therapy for ulcerative colitis (UC). We conducted a multicenter retrospective cohort study that included 7 European countries and Israel to examine whether infliximab discontinuation can be considered for patients who achieve sustained remission. Methods We performed a retrospective cohort study, collecting medical records from 13 tertiary care referral inflammatory bowel disease centers of all patients with UC treated with infliximab (n = 193...
30 CitationsSource
Close Researchers
F. Magro
H-index : 4
University of Cambridge
Peter Lakatos
H-index : 7
Semmelweis University
Natalia Pedersen
H-index : 5
Herlev Hospital
Marco Silva
H-index : 8
Hospital de São João
Gionata Fiorino
H-index : 51
Humanitas University
Carla Felice
H-index : 20
University of Padua
L. Kievit
H-index : 1
Bella Ungar
H-index : 19
Sheba Medical Center
Svetlana Turcan
H-index : 12
Gerassimos J. Mantzaris
H-index : 48
Hospital Universitario de Canarias
Federica Furfaro
H-index : 18
University of Milan
Uri Kopylov
H-index : 46
Tel Aviv University
Konstantinos Karmiris
H-index : 25
Katholieke Universiteit Leuven
Vincent Hernández Ramírez
Limas Kupcinskas
H-index : 1
Corvinus University of Budapest
Pia S. Munkholm
H-index : 5
Statens Serum Institut
Mathurin Fumery
H-index : 10
French Institute of Health and Medical Research
Martina Muscat
H-index : 2
Mater Dei Hospital
Konstantinos H. Katsanos
H-index : 4
Katholieke Universiteit Leuven
M. Giannotta
H-index : 2
Pia Oksanen
H-index : 6
University of Tampere
Vibeke Andersen
H-index : 38
University of Southern Denmark
Elena Belousova
H-index : 14
Dimitrios K. Christodoulou
H-index : 26
RMIT University
Renata D'Incà
H-index : 60
University of Padua
Stefanos Bonovas
H-index : 40
Humanitas University
Fabrizio Bossa
H-index : 31
Casa Sollievo della Sofferenza
K. R. Nielsen
H-index : 15
Jens Frederik Dahlerup
H-index : 36
Aarhus University Hospital
Naila Arebi
H-index : 22
Imperial College London
Adrian Goldis
H-index : 21
Fernando Magro
H-index : 41
University of Porto
I. Kaimakliotis
H-index : 13
Konstantinos H. Katsanos
H-index : 35
RMIT University
Pantelis Karatzas
H-index : 11
National and Kapodistrian University of Athens
Marta Maia Bosca-Watts
H-index : 8
University of Valencia
Peter L. Lakatos
H-index : 84
McGill University Health Centre
Pablo Navarro Cortes
H-index : 1
Pierre Ellul
Sheba Medical Center
Dana Duricova
H-index : 1
University of Picardie Jules Verne
Doron Schwartz
H-index : 1
Sheba Medical Center
Daniela Valpiani
H-index : 17
Johan Burisch
H-index : 38
Copenhagen University Hospital
Jonas Halfvarson
H-index : 54
Örebro University
Ebbe Langholz
H-index : 47
University of Copenhagen
Silvija Čuković-Čavka
H-index : 15
University of Zagreb
Riina Salupere
H-index : 20
Tartu University Hospital
Hillel Vardi
H-index : 21
Ben-Gurion University of the Negev
Zsuzsanna Vegh
H-index : 20
Semmelweis University
Selwyn Odes
H-index : 22
Ben-Gurion University of the Negev
Alessandro Armuzzi
H-index : 58
Catholic University of the Sacred Heart
Shomron Ben-Horin
H-index : 57
Sheba Medical Center
Giovanni Maconi
H-index : 56
University of Milan
Pierre Ellul
H-index : 18
Mater Dei Hospital
Silvio Danese
H-index : 100
Humanitas University